Trade Allogene Therapeutics, Inc. - ALLO CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.03
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02218 %(-$0.44)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.02218%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.00004 %(-$0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.00004%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02218 %
  (-$0.44)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00004 %
  (-$0.00)

Key Stats

• Prev. Close: 1.45
• Open: 1.43
• 1-Year Change: 17.21%
• Day's Range: 1.39 - 1.44

Trade Allogene Therapeutics, Inc. - ALLO

Allogene Therapeutics, Inc. (NASDAQ: ALLO) is a clinical-stage biotech company pioneering allogeneic CAR-T cell therapies for cancer. Unlike autologous treatments, Allogene’s off-the-shelf approach aims to reduce cost, manufacturing time, and scalability challenges in cell therapy. Its lead candidates target hematologic malignancies such as lymphoma and multiple myeloma. With partnerships, in-house manufacturing, and robust IP, Allogene provides high-risk, high-reward exposure to next-generation immuno-oncology.